← Leaderboards
Masayuki Yazawa
Stanford University
$6,289,286
Attributed
$7,311,867
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,311,867 · 6
By mechanism
R01$5,991,404 · 3
R00$737,042 · 1
R56$410,837 · 1
K99$172,584 · 1
Top collaborators
- Lei Ding6 shared
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- James A Spudich$18,041,927
- Lei Stanley Qi$14,888,989
- Mark Mercola$44,191,191
- Marlene Rabinovitch$40,032,014
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VitroCellsInnovationGenesMuscle CellsPhenotypePhysiologicalPlayArrhythmiaHeartIn VivoAction PotentialsExperimental StudyCouplingLong Qt SyndromeCardiac MyocytesGeneticInduced Pluripotent Stem CellCardiacDesignGene ExpressionHeart FunctionFunctional Disorder
Grant awards (21)
Novel Therapeutics for Timothy Syndrome and Related Cardiac Channelopathy$635,816
R01 · FY2025 · HL · contact PI
Developing Next Generation Genetics for Understanding Hematopoietic Stem Cell Biology$417,834
R01 · FY2025 · GM · contact PI
Novel Therapeutics for Timothy Syndrome and Related Cardiac Channelopathy$618,866
R01 · FY2024 · HL · contact PI
Developing Next Generation Genetics for Understanding Hematopoietic Stem Cell Biology$418,045
R01 · FY2024 · GM · contact PI
Confocal illumination system to apply optogenetic tools for hematopoietic stem cell biology with single cell resolution$249,972
R01 · FY2024 · GM · contact PI
Novel Therapeutics for Timothy Syndrome and Related Cardiac Channelopathy$709,414
R01 · FY2023 · HL · contact PI
Developing Next Generation Genetics for Understanding Hematopoietic Stem Cell Biology$435,214
R01 · FY2023 · GM · contact PI
Developing Next Generation Genetics for Understanding Hematopoietic Stem Cell Biology$1
R01 · FY2023 · GM · contact PI
Developing Next Generation Genetics for Understanding Hematopoietic Stem Cell Biology$524,097
R01 · FY2022 · GM · contact PI
Novel Therapeutics for Long QT Syndrome$245,540
R56 · FY2022 · HL · contact PI
Novel Therapeutics for Long QT Syndrome$165,297
R56 · FY2022 · HL · contact PI
Molecular mechanisms underlying cardiac sodium channelopathy$397,594
R01 · FY2021 · HL · contact PI
Molecular mechanisms underlying cardiac sodium channelopathy$396,603
R01 · FY2020 · HL · contact PI
Molecular mechanisms underlying cardiac sodium channelopathy$395,962
R01 · FY2019 · HL · contact PI
Molecular mechanisms underlying cardiac sodium channelopathy$395,968
R01 · FY2018 · HL · contact PI
Molecular mechanisms underlying cardiac sodium channelopathy$396,018
R01 · FY2017 · HL · contact PI
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells$244,021
R00 · FY2015 · HL · contact PI
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells$244,021
R00 · FY2014 · HL · contact PI
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells$249,000
R00 · FY2013 · HL · contact PI
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells$86,292
K99 · FY2013 · HL · contact PI
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells$86,292
K99 · FY2012 · HL · contact PI